OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP. Share Price

Certificat

DE000GQ9BXW8

Market Closed - BOERSE MUENCHEN 11:57:07 14/06/2024 pm IST
4.38 EUR +0.46% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - STRYKER CORP.
Current month+7.88%
1 month+58.70%
Date Price Change
14/24/14 4.38 +0.46%
13/24/13 4.36 -9.17%
12/24/12 4.8 +3.90%
11/24/11 4.62 -2.53%
10/24/10 4.74 -5.95%

Real-time BOERSE MUENCHEN

Last update June 14, 2024 at 11:57 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GQ9BXW
ISINDE000GQ9BXW8
Date issued 20/11/2023
Strike 296.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.74
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.52
Lowest since issue 0.54
Spread 0.07
Spread %1.52%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus